Blume-Jensen Peter sold ACRV
May 14, 2026 · Form 4 insider transaction
Blume-Jensen Peter sold 490 shares of Acrivon Therapeutics, Inc. at $1.92 per share, a transaction worth $940.80. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
490
Price
$1.92
Total value
$940.80
InsiderBlume-Jensen Peter
RoleOfficer, Director
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMay 14, 2026
Filing dateMay 18, 2026
Shares owned after313,637
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.; These securities are held by co-founder and EVP, Dr. Kristina Masson, who is also Dr. Blume-Jensen's spouse. Dr. Blume-Jensen disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.